Deutsche Bank’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,901
| Closed | -$2.3K | – | 3524 |
|
2024
Q2 | $2.3K | Sell |
1,901
-42,770
| -96% | -$51.7K | ﹤0.01% | 3452 |
|
2024
Q1 | $105K | Sell |
44,671
-1,035
| -2% | -$2.43K | ﹤0.01% | 3105 |
|
2023
Q4 | $86.4K | Buy |
45,706
+40,088
| +714% | +$75.8K | ﹤0.01% | 3238 |
|
2023
Q3 | $7.7K | Sell |
5,618
-1,015,485
| -99% | -$1.39M | ﹤0.01% | 3522 |
|
2023
Q2 | $2.48M | Buy |
1,021,103
+989,689
| +3,150% | +$2.4M | ﹤0.01% | 1521 |
|
2023
Q1 | $181K | Sell |
31,414
-651,770
| -95% | -$3.75M | ﹤0.01% | 3047 |
|
2022
Q4 | $6.11M | Buy |
683,184
+7,208
| +1% | +$64.4K | ﹤0.01% | 1141 |
|
2022
Q3 | $9.61M | Sell |
675,976
-1,889
| -0.3% | -$26.9K | 0.01% | 968 |
|
2022
Q2 | $9.9M | Buy |
677,865
+55
| +0% | +$803 | 0.01% | 996 |
|
2022
Q1 | $13.5M | Buy |
677,810
+649,407
| +2,286% | +$13M | 0.01% | 969 |
|
2021
Q4 | $497K | Buy |
28,403
+662
| +2% | +$11.6K | ﹤0.01% | 2838 |
|
2021
Q3 | $217K | Buy |
27,741
+15,325
| +123% | +$120K | ﹤0.01% | 3494 |
|
2021
Q2 | $128K | Buy |
+12,416
| New | +$128K | ﹤0.01% | 3965 |
|
2020
Q3 | – | Sell |
-186
| Closed | -$3K | – | 4198 |
|
2020
Q2 | $3K | Sell |
186
-6,086
| -97% | -$98.2K | ﹤0.01% | 4086 |
|
2020
Q1 | $45K | Sell |
6,272
-44
| -0.7% | -$316 | ﹤0.01% | 3515 |
|
2019
Q4 | $65K | Buy |
6,316
+5,760
| +1,036% | +$59.3K | ﹤0.01% | 3728 |
|
2019
Q3 | $34K | Sell |
556
-46
| -8% | -$2.81K | ﹤0.01% | 3967 |
|
2019
Q2 | $42K | Sell |
602
-494
| -45% | -$34.5K | ﹤0.01% | 4341 |
|
2019
Q1 | $51K | Buy |
1,096
+36
| +3% | +$1.68K | ﹤0.01% | 4346 |
|
2018
Q4 | $63K | Sell |
1,060
-1,455
| -58% | -$86.5K | ﹤0.01% | 4178 |
|
2018
Q3 | $267K | Buy |
2,515
+575
| +30% | +$61K | ﹤0.01% | 4017 |
|
2018
Q2 | $125K | Buy |
1,940
+745
| +62% | +$48K | ﹤0.01% | 4297 |
|
2018
Q1 | $80K | Buy |
+1,195
| New | +$80K | ﹤0.01% | 4370 |
|